跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 47,179 条关于
“topoisomerase I inhibitor”
全部
47,179
临床试验
31,288
药物
4,622
机构
117
资讯
11,152
2年前
FDA Clears IND Application for Zymeworks' Novel FRα-Targeted ADC, ZW191
去年
FDA Clears IND for SystImmune's BL-M11D1 in Relapsed/Refractory AML
5个月前
Phrontline Biopharma's TJ106 Shows Promise Against HER2-Low and ADC-Resistant Tumors in Preclinical Studies
去年
FDA Clears IND for Adcendo's Novel Tissue Factor-Targeting ADC in Advanced Solid Tumors
去年
FDA Grants Fast Track Designation to CBP-101 for Recurrent Endometrial Cancer Treatment
上个月
Bio-Thera Solutions Doses First Patient in Phase 1 Trial of CD25-Targeting ADC BAT8013 for Advanced Solid Tumors
去年
Sacituzumab Tirumotecan NDA Accepted in China for Pretreated EGFR-Mutant NSCLC
去年
DEP-SN38 Dendrimer Nanoparticle Shows Promise in Advanced Solid Tumors with Reduced Toxicity Profile
去年
FDA Grants Fast Track Designation to Alentis Therapeutics' ALE.P02 for CLDN1+ Squamous Cancers
去年
Astellas Secures $1.4 Billion License Deal for Novel CLDN18.2-Targeting ADC XNW27011
第 1 页,共 1116 页
上一页
下一页